Back to Search
Start Over
A summary of surveillance, morbidity and microbiology of laboratory-confirmed cases of infant botulism in Canada, 1979–2019
- Source :
- Canada Communicable Disease Report, Vol 47, Iss 78, Pp 322-328 (2021), Can Commun Dis Rep
- Publication Year :
- 2021
- Publisher :
- Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada, 2021.
-
Abstract
- Background: Infant botulism is a rare toxicoinfectious disease caused by colonization of the infant’s intestine with botulinum neurotoxin-producing clostridia (i.e. Clostridium botulinum or neurotoxigenic strains of C. butyricum or C. baratii). Our goal was to examine data from laboratory-confirmed cases of infant botulism reported in Canada to summarize incidence over time, over geographic distribution by province or territory, and by sex, and to compare these parameters with data from the Canadian Notifiable Disease Surveillance System (CNDSS). The average age of onset, serotype of botulinum neurotoxin (BoNT), case outcomes, length of hospitalization and suitability of clinical specimens for laboratory confirmation were also determined. Methods: We examined laboratory records from the Health Canada Botulism Reference Service and the British Columbia Centre for Disease Control (BCCDC) Public Health Laboratory. The Discharge Abstract Database (DAD) and the Hospital Morbidity Database (HMDB) of the Canadian Institute of Health Information (CIHI) were queried for data on hospitalization of infant botulism cases. The CNDSS was queried for data on reported cases of infant botulism. Results: From 1979 to 2019, 63 laboratory-confirmed cases of infant botulism were confirmed by the Health Canada Botulism Reference Service and the BCCDC Public Health Laboratory for an annual rate of 4.30 cases per million live births. From 1983 to 2018, 57 cases of infant botulism were reported to the CNDSS. Of the 63 cases confirmed by the reference laboratories, the median age of onset was 16 weeks with a range of 2 to 52 weeks. The majority of cases were type A (76%) and B (21%), with single cases of type F and type AB. Of the 23 laboratory-confirmed cases with matched hospital records, 13 were transferred to special care and eight needed ventilator support; no deaths were reported. Conclusion: Spores of C. botulinum are present naturally in the environment, thus diagnosis of infant botulism does not require a history of exposure to high-risk foods such as honey. Stool samples are the most useful diagnostic specimen.
- Subjects :
- medicine.medical_specialty
Pediatrics
canada
Notifiable disease
Infectious and parasitic diseases
RC109-216
medicine.disease_cause
clostridium botulinum
geographic distribution
Medicine
Botulism
serotype
Surveillance
biology
business.industry
Incidence (epidemiology)
Public health
Infant Botulism
incidence rate
botulinum neurotoxin
General Medicine
clostridium baratii
biology.organism_classification
medicine.disease
environmental source
clostridium butyricum
Clostridium baratii
Clostridium botulinum
Age of onset
business
Subjects
Details
- ISSN :
- 14818531
- Volume :
- 47
- Database :
- OpenAIRE
- Journal :
- Canada Communicable Disease Report
- Accession number :
- edsair.doi.dedup.....8ce49d2f27768e1375f75abca9384b68